XTL BIOPHARMACEUTICALS LTD
For the period ended Jun 22, 2026. Filed Jun 23, 2026.
View on SEC.govAbout this filing
What a company based outside the US has published at home or sent to its shareholders. It is how many foreign companies share results and news between annual reports.
Jun 22, 2026 · Filed Jun 23, 2026
Use the contents to explore the available documents and sections.
XTLB$1.55-9.4%Stored close · as of Nov 6, 2026
Contents
Cover page
Show cover page
6-K 1 ea0295469-6k_xtlbio.htm REPORT OF FOREIGN PRIVATE ISSUER
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 6-K
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.